Afuco™ Anti-Human NCSTN ADCC Therapeutic Antibody (A5226A), ADCC Enhanced
Anti-NCSTN ADCC Enhanced Antibody (A5226A) is an ADCC enhanced antibody produced by our Afuco™ platform. A novel monoclonal antibody A5226A is against the extracellular domain of NCT. A5226A by targeting NCT might be a novel therapeutic strategy against cancer caused by aberrant γ-secretase activity and Notch signaling.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-714CL |
| Pricing | Inquiry |
| Target | NCSTN |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | IP, ICC, FuncS, Inhib, IF |
| Storage | Can be stored at 4°C. For long term storage, aliquot and store at -20°C. Avoid repeated freezing and thawing cycles. |